Birdwatch Note
2024-04-12 22:15:28 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
ターボ癌という医学用語は存在しません https://tenjin-cc.net/blog/884/ SNS上で拡散されている造語で科学的根拠もありません https://www.sankei.com/article/20221209-7LLB3VRMZZBUFADO7VUPKN2RPY/ mRNAワクチンが免疫力を低下させ癌を誘発するという科学的根拠はありません むしろ、mRNAワクチンによる癌治療が始まっています https://www.cas.org/ja/resources/cas-insights/biotechnology/fighting-viruses-tackling-tumors-harnessing-mrna-vaccines https://www.igakuken.or.jp/r-info/covid-19-info168.html ただし、基礎疾患を持つ人に反復接種する事で免疫力を抑制する可能性がある事に留意が必要です https://www.yuki-clinic.jp/diary/diary-1794/ 引用されている連新社は、過去何度もフェイクニュースを投稿しているアカウントであることにも注意が必要です https://ja.wikipedia.org/wiki/%E6%96%B0%E4%B8%AD%E5%9B%BD%E9%80%A3%E9%82%A6#%E6%97%A5%E6%9C%AC%E3%81%A7%E3%81%AE%E6%B4%BB%E5%8B%95
Written by 7A9FF9E0AC22B46DA9E28988C69E88AB84BA7BDC51EFDA1B44D021A9037A2442
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1778850741081272337
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1778909829505094141
- noteId - 1778909829505094141
- participantId -
- noteAuthorParticipantId - 7A9FF9E0AC22B46DA9E28988C69E88AB84BA7BDC51EFDA1B44D021A9037A2442 Participant Details
- createdAtMillis - 1712960128558
- tweetId - 1778850741081272337
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 1
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- ターボ癌という医学用語は存在しません https://tenjin-cc.net/blog/884/ SNS上で拡散されている造語で科学的根拠もありません https://www.sankei.com/article/20221209-7LLB3VRMZZBUFADO7VUPKN2RPY/ mRNAワクチンが免疫力を低下させ癌を誘発するという科学的根拠はありません むしろ、mRNAワクチンによる癌治療が始まっています https://www.cas.org/ja/resources/cas-insights/biotechnology/fighting-viruses-tackling-tumors-harnessing-mrna-vaccines https://www.igakuken.or.jp/r-info/covid-19-info168.html ただし、基礎疾患を持つ人に反復接種する事で免疫力を抑制する可能性がある事に留意が必要です https://www.yuki-clinic.jp/diary/diary-1794/ 引用されている連新社は、過去何度もフェイクニュースを投稿しているアカウントであることにも注意が必要です https://ja.wikipedia.org/wiki/%E6%96%B0%E4%B8%AD%E5%9B%BD%E9%80%A3%E9%82%A6#%E6%97%A5%E6%9C%AC%E3%81%A7%E3%81%AE%E6%B4%BB%E5%8B%95
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-04-12 22:15:28 UTC (1712960128558) |
2024-04-13 05:11:35 UTC (1712985095908) |
CURRENTLY_RATED_HELPFUL | 2024-04-15 04:12:13 UTC (1713154333742) |
CURRENTLY_RATED_HELPFUL | 2024-04-13 05:11:35 UTC (1712985095908) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-04-12 21:17:57 -0500 | Rating Details | |
2024-04-12 20:24:30 -0500 | Rating Details | |
2024-04-12 19:20:29 -0500 | Rating Details | |
2024-04-12 19:19:38 -0500 | Rating Details | |
2024-04-12 18:18:28 -0500 | Rating Details | |
2024-04-12 17:54:13 -0500 | Rating Details | |
2024-04-12 17:53:54 -0500 | Rating Details | |
2024-04-12 17:46:56 -0500 | Rating Details | |
2024-04-12 17:46:24 -0500 | Rating Details | |
2024-04-12 17:46:14 -0500 | Rating Details | |
2024-04-12 17:44:34 -0500 | Rating Details | |
2024-04-12 17:42:37 -0500 | Rating Details | |
2024-04-12 17:42:05 -0500 | Rating Details | |
2024-04-12 17:41:28 -0500 | Rating Details | |
2024-04-12 17:41:05 -0500 | Rating Details | |
2024-04-12 17:38:44 -0500 | Rating Details | |
2024-04-13 23:26:37 -0500 | Rating Details | |
2024-04-13 21:32:30 -0500 | Rating Details | |
2024-04-13 18:03:49 -0500 | Rating Details | |
2024-04-13 16:45:20 -0500 | Rating Details | |
2024-04-13 07:56:30 -0500 | Rating Details | |
2024-04-13 02:58:11 -0500 | Rating Details | |
2024-04-13 02:02:03 -0500 | Rating Details | |
2024-04-12 23:44:04 -0500 | Rating Details | |
2024-04-12 23:33:32 -0500 | Rating Details | |
2024-04-15 04:34:34 -0500 | Rating Details | |
2024-04-13 18:38:12 -0500 | Rating Details | |
2024-04-13 13:53:59 -0500 | Rating Details | |
2024-04-13 09:42:41 -0500 | Rating Details | |
2024-04-13 08:12:59 -0500 | Rating Details | |
2024-04-13 05:52:36 -0500 | Rating Details | |
2024-04-13 05:50:04 -0500 | Rating Details | |
2024-04-13 02:37:15 -0500 | Rating Details | |
2024-04-13 01:36:19 -0500 | Rating Details | |
2024-04-13 01:27:05 -0500 | Rating Details | |
2024-04-12 23:18:22 -0500 | Rating Details | |
2024-04-12 22:41:47 -0500 | Rating Details | |
2024-04-12 22:17:59 -0500 | Rating Details | |
2024-04-12 21:28:32 -0500 | Rating Details | |
2024-04-12 20:02:53 -0500 | Rating Details | |
2024-04-12 19:54:44 -0500 | Rating Details | |
2024-04-12 19:09:40 -0500 | Rating Details | |
2024-04-12 18:30:06 -0500 | Rating Details | |
2024-04-12 18:19:26 -0500 | Rating Details | |
2024-04-12 18:03:13 -0500 | Rating Details | |
2024-04-12 18:00:33 -0500 | Rating Details | |
2024-04-12 17:45:28 -0500 | Rating Details | |
2024-04-12 17:18:02 -0500 | Rating Details | |
2024-04-16 16:59:31 -0500 | Rating Details | |
2024-04-13 02:30:25 -0500 | Rating Details | |
2024-04-13 18:12:10 -0500 | Rating Details | |
2024-04-13 23:29:28 -0500 | Rating Details | |
2024-04-13 20:43:54 -0500 | Rating Details | |
2024-04-13 12:41:22 -0500 | Rating Details | |
2024-04-13 12:12:03 -0500 | Rating Details | |
2024-04-13 07:05:45 -0500 | Rating Details | |
2024-04-13 05:38:22 -0500 | Rating Details | |
2024-04-13 03:49:48 -0500 | Rating Details | |
2024-04-13 02:21:02 -0500 | Rating Details | |
2024-04-12 23:42:25 -0500 | Rating Details | |
2024-04-12 22:34:30 -0500 | Rating Details | |
2024-04-12 21:38:37 -0500 | Rating Details | |
2024-04-12 21:04:19 -0500 | Rating Details | |
2024-04-12 20:05:37 -0500 | Rating Details | |
2024-04-12 19:41:08 -0500 | Rating Details | |
2024-04-12 19:20:23 -0500 | Rating Details | |
2024-04-12 19:07:16 -0500 | Rating Details | |
2024-04-12 19:01:36 -0500 | Rating Details | |
2024-04-12 18:47:43 -0500 | Rating Details | |
2024-04-12 18:39:59 -0500 | Rating Details | |
2024-04-12 18:39:24 -0500 | Rating Details | |
2024-04-12 18:16:43 -0500 | Rating Details | |
2024-04-12 18:09:28 -0500 | Rating Details | |
2024-04-12 17:59:46 -0500 | Rating Details | |
2024-04-12 17:57:40 -0500 | Rating Details | |
2024-04-12 17:48:25 -0500 | Rating Details |